Board logo

subject: Australia In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 [print this page]


Australia In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Australia In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Australia

Scope

- The report provides information on the Australian in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.

- Total revenues, end users

- Market shares of all the key competitors.

- Key pipeline products that are set to shape the market, broken down by sector.

- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.

- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.

- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

- Key mergers and acquisitions, partnerships, private equity investments and IPOs.

- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the in vitro diagnostics devices market in Australia.

- Evaluate and compare the attractiveness of the market in the country.

- Identify growth segments and opportunities in each industry sector within the country.

- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.

- Analyze the competitiveness of the market in the country and identify hotspots.

- Develop strategies based on the latest product, brand, expansion and research and development news in the country.

- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.

- Identify and analyze the strengths and weaknesses of the industry incumbents in the country. F. Hoffmann-La Roche Ltd.

Siemens Healthcare

Sysmex Corporation

Abbott Laboratories

Beckman Coulter, Inc.

Ortho-Clinical Diagnostics Inc.

OLYMPUS CORPORATION

Qiagen N.V.

bioMerieux S.A.

Bio-Rad Laboratories, Inc.

Phadia AB

DiaSorin S.p.A

Becton, Dickinson and Company

Gen-Probe Incorporated

Inverness Medical Innovations, Inc.

Dade Behring Holdings, Inc.

Ventana Medical Systems, Inc.

Vision BioSystems Ltd

Cellestis Limited

GeneWorks Pty. Ltd.

Astral Scientific Pty Ltd

Enterix Australia Pty Ltd

Cellabs Pty Ltd

Diagnostic Technology

Universal Biosensors, Inc.

Panbio Limited For more information, please visit : http://www.aarkstore.com/reports/Australia-In-Vitro-Diagnostics-Investment-Opportunities-Analysis-and-Forecasts-to-2015-7817.html Or email us at press@aarkstore.com or call +919272852585

Australia In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

By: Aarkstore Enterprise




welcome to Insurances.net (https://www.insurances.net) Powered by Discuz! 5.5.0   (php7, mysql8 recode on 2018)